265 related articles for article (PubMed ID: 9060663)
1. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.
Caley IJ; Betts MR; Irlbeck DM; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
J Virol; 1997 Apr; 71(4):3031-8. PubMed ID: 9060663
[TBL] [Abstract][Full Text] [Related]
2. Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy.
Caley IJ; Betts MR; Davis NL; Swanstrom R; Frelinger JA; Johnston RE
Vaccine; 1999 Aug; 17(23-24):3124-35. PubMed ID: 10462249
[TBL] [Abstract][Full Text] [Related]
3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
4. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.
Davis NL; Brown KW; Johnston RE
J Virol; 1996 Jun; 70(6):3781-7. PubMed ID: 8648713
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.
Gupta S; Janani R; Bin Q; Luciw P; Greer C; Perri S; Legg H; Donnelly J; Barnett S; O'Hagan D; Polo JM; Vajdy M
J Virol; 2005 Jun; 79(11):7135-45. PubMed ID: 15890953
[TBL] [Abstract][Full Text] [Related]
6. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
[TBL] [Abstract][Full Text] [Related]
7. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
[TBL] [Abstract][Full Text] [Related]
8. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
J Virol; 2021 May; 95(12):. PubMed ID: 33789991
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
[TBL] [Abstract][Full Text] [Related]
10. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
[TBL] [Abstract][Full Text] [Related]
11. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
[TBL] [Abstract][Full Text] [Related]
13. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
[TBL] [Abstract][Full Text] [Related]
14. Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges.
Khattar SK; Manoharan V; Bhattarai B; LaBranche CC; Montefiori DC; Samal SK
mBio; 2015 Jul; 6(4):e01005. PubMed ID: 26199332
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.
Qiu JT; Liu B; Tian C; Pavlakis GN; Yu XF
J Virol; 2000 Jul; 74(13):5997-6005. PubMed ID: 10846081
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles.
Vajdy M; Gardner J; Neidleman J; Cuadra L; Greer C; Perri S; O'Hagan D; Polo JM
J Infect Dis; 2001 Dec; 184(12):1613-6. PubMed ID: 11740739
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.
Zhang H; Fayad R; Wang X; Quinn D; Qiao L
J Virol; 2004 Oct; 78(19):10249-57. PubMed ID: 15367590
[TBL] [Abstract][Full Text] [Related]
19. Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery.
Goodsell A; Zhou F; Gupta S; Singh M; Malyala P; Kazzaz J; Greer C; Legg H; Tang T; Zur Megede J; Srivastava R; Barnett SW; Donnelly JJ; Luciw PA; Polo J; O'Hagan DT; Vajdy M
Immunology; 2008 Mar; 123(3):378-89. PubMed ID: 17944930
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.
Qiu JT; Song R; Dettenhofer M; Tian C; August T; Felber BK; Pavlakis GN; Yu XF
J Virol; 1999 Nov; 73(11):9145-52. PubMed ID: 10516021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
